Client Case Study: Insight Investment
Building a market leader with technology that connects the data with the models; quickly, flexibly, transparently.
“Xenomorph’s TimeScape is a robust and scalable OTC enabling technology; the flexible data model and subsequent data accessibility are key factors in our ability to support the use of OTC instruments.”
Gareth Exell, Head of IT Strategy, Insight Investment.
 |
Download the complete Insight Investment Case Study PDF. |
Overview
Country/Region: United Kingdom
Industry: Asset Management
Customer Profile:
Launched in 2002, Insight Investment has over £119 billion in assets under management*. With a wide range of OTC products and significant growth targets for more products to come on line, the Insight Derivatives Project Team leads the way in developing all-round solutions to provide OTCs to suit the market.
Business Situation:
To develop the derivative capabilities fundamental to the LDI platform, Insight needed to:
- Quickly merge the IT systems and business processes found in the three organisations
- Build an end-to-end system to cope with any type of derivative
- Build a platform that would be able to handle the large volume of complex products that were being forecast
Solution:
TimeScape has provided Insight with a platform that can handle the variety and volume of OTCs required. The data is centralised based on a flexible data model which can support any kind of instrument. The TimeScape pricing engine supports both proprietary and off the shelf pricing models that can be supplemented in-house as new instrument types are added.
- Support for any type of OTC
- No vendor involvement necessary to support new instruments and models
- Centralised and consistent access to both security data and pricing analytics
- Faster and more controlled processing of OTCs
* As at 31 December 2008, see www.insightinvestment.com
Download
|
Download the complete Insight Investment Case Study PDF. |